Dr. John Overholt shares with host Liz Edwards some good news! Starting this summer, major manufacturers will cap patients' out-of-cost expense for inhalers.
This restriction on pricing is long overdue as some asthma patients are forced to limit the use of their inhalers because of its cost. Dr. Overholt shares how common it is for patients to use inhalers less frequently than prescribed and how dangerous that practice can be, creating more illness, more ER visits, and even the need for additional meds; but for those who can't afford the $400-$500 cost per month, it's a necessary maneuver. As Dr. Overholt explains, "A medication you can't afford is not a good medication."
Learn when specific companies will begin capping their products' costs and how this change will empower providers to prescribe the inhaler that works best for the patient instead of the one that's most affordable.
